PREZIOSO, CARLA
 Distribuzione geografica
Continente #
AS - Asia 360
NA - Nord America 267
EU - Europa 80
SA - Sud America 17
AF - Africa 3
Totale 727
Nazione #
US - Stati Uniti d'America 240
SG - Singapore 170
CN - Cina 101
TR - Turchia 76
IT - Italia 39
DE - Germania 23
CA - Canada 22
BR - Brasile 15
FI - Finlandia 5
NL - Olanda 5
HK - Hong Kong 4
MX - Messico 4
GB - Regno Unito 3
ES - Italia 2
IN - India 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
CL - Cile 1
EG - Egitto 1
IR - Iran 1
KR - Corea 1
PH - Filippine 1
RO - Romania 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 727
Città #
Singapore 54
Santa Clara 51
San Mateo 39
Kocaeli 34
Dallas 20
Toronto 19
Ashburn 16
Assago 16
Guangzhou 15
Rome 15
Shanghai 14
Shenzhen 11
Beijing 9
Frankfurt am Main 8
Wilmington 7
Brooklyn 6
Lawrence 6
Princeton 6
West Jordan 6
Helsinki 5
Los Angeles 5
Munich 5
The Dalles 5
Boston 4
Hong Kong 4
Jiaxing 3
Americana 2
New York 2
Seattle 2
Tokyo 2
Wuxi 2
Xi'an 2
Alexandrov 1
Amsterdam 1
Anaheim 1
Andalusia 1
Arouca 1
Astolfo Dutra 1
Atlanta 1
Belo Horizonte 1
Birmingham 1
Campinas 1
Cantalupo In Sabina 1
Carapicuíba 1
Carmo do Cajuru 1
Chandler 1
Chennai 1
Chicago 1
Cleveland 1
Collingwood 1
Coronel 1
Cosenza 1
Council Bluffs 1
Cássia 1
Dammam 1
Denver 1
Dongyang 1
Fort Worth 1
Foshan 1
Foz do Iguaçu 1
Fuzhou 1
Gebze 1
Giza 1
Granada 1
Huzhou 1
Irving 1
Jining 1
LaSalle 1
Leicester 1
Liverpool 1
Luanda 1
Makiyivka 1
Manila 1
Marília 1
Mexico 1
Milan 1
Montreal 1
Nanjing 1
New Delhi 1
Perugia 1
Peschiera 1
Peterborough 1
Phoenix 1
Pittsburgh 1
Putian 1
Quixadá 1
Raleigh 1
Recife 1
Richmond 1
Rockville 1
Rui'an 1
Santa Fe 1
Seoul 1
Shijiazhuang 1
Syracuse 1
São Paulo 1
Taizhou 1
Tarija 1
Terra Nova do Norte 1
Uberlândia 1
Totale 463
Nome #
d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications 46
Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation 46
COS-7-based model: methodological approach to study John Cunningham virus replication cycle 44
d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications. 41
SARS-CoV-2: Comparative analysis of different RNA extraction methods 38
Merkel Cell Polyomavirus (MCPyV) in the Context of Immunosuppression: Genetic Analysis of Noncoding Control Region (NCCR) Variability Among a HIV-1-Positive Population 35
COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains 20
Evaluation of redox state alterations in influenza A virus-infected neuronal cells: involvement in neurotropism. 20
Characterization of Human Polyomavirus JC (JCPyV) infection in Human Neuroblastoma SH-SY5Y cells and evaluation of redox state during viral replication 18
Detection analysis and study of genomic region variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the urine and plasma of HIV-1-infected patients 17
John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy 17
Genetic Diversity of the Noncoding Control Region of the Novel Human Polyomaviruses 15
High prevalence of Merkel cell polyomavirus is associated with dysregulation in transcript levels of TLR9 and type I IFNs in a large cohort of CF patients from the Italian (Lazio) reference center for cystic fibrosis 15
Functional Domains of the Early Proteins and Experimental and Epidemiological Studies Suggest a Role for the Novel Human Polyomaviruses in Cancer 15
Stillbirth and fetal capillary infection by SARS-CoV-2 14
Evaluation of merkel cell polyomavirus DNA in tissue samples from italian patients with diagnosis of MCC 14
BK virus and transplantation 14
SARS-CoV-2 epidemiological surveillance of healthcare professionals working in an inpatient rehabilitation facility 14
HPyV6 and HPyV7 in urine from immunocompromised patients 13
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 13
Structural analysis of merkel cell polyomavirus (MCPyV) viral capsid protein 1 (VP1) in HIV-1 infected individuals 13
Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection 13
Identification and Antimicrobial Susceptibility Testing of Microorganisms From Positive blood Cultures by a Combined Lysis-centrifugation Method with MALDI-TOF MS and VITEK2 System 12
Kidney graft failure induced by BKPyV replication despite a strong reduction of the immunosuppressive therapy 12
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma 12
Common microbial genital infections and their impact on the innate immune response to HPV in cervical cells 12
JC polyomavirus. A short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence 12
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 12
Detection of Merkel cell polyomavirus (mcpyv) dna and transcripts in Merkel cell carcinoma (mcc) 12
Detection of Quebec polyomavirus DNA in samples from different patient groups 11
Reply to Henriksen, S.; Rinaldo, C.H. Should SVGp12 be used for JC polyomavirus studies? comment on “prezioso et al. COS-7 and SVGp12 cellular models to study JCPyV replication and microRNA expression after infection with archetypal and rearranged-NCCR viral strains. Viruses 2022, 14, 2070 11
The inhibition of DNA viruses by the amphibian antimicrobial peptide temporin G. A virological study addressing HSV-1 and JPCyV 11
Merkel cell polyomavirus and Merkel cell carcinoma 11
COVID-19. Update of the Italian situation 11
Regulation of transcriptional activity of Merkel cell polyomavirus large T-Antigen by PKA-mediated phosphorylation 11
Merkel cell polyomavirus DNA detection in respiratory samples: study of a cohort of patients affected by cystic fibrosis 10
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? 10
The "Three Italy" of the COVID-19 epidemic and the possible Involvement of SARS-CoV-2 in triggering complications other than pneumonia 10
Increased prevalence of Human Polyomavirus JC viruria in Chronic Inflammatory Rheumatic Diseases patients in treatment with anti-TNF α: a 18 month follow-up study 10
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 10
Effect of Cigarette Smoking on Clinical and Molecular Endpoints in COPD Patients 10
Role of virus-induced host cell epigenetic changes in cancer 10
Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment 10
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 10
Polyomaviruses shedding in stool of patients with hematological disorders: detection analysis and study of the non-coding control region’s genetic variability 9
Antibacterial and Anti-Influenza Activities of N-Heterocyclic Carbene–Gold Complexes 9
KI and WU polyomavirus in respiratory samples of sars‐cov‐2 infected patients 9
Prevalence of MCPyV, HPyV6, HPyV7 and TSPyV in Actinic Keratosis Biopsy Specimens 7
The effect of Torque Teno Virus (TTV) Infection on Clinical Outcomes, Genomic Integrity, and Mortality in COPD Patients 6
Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time 6
Correlation between Chest Computed Tomography Score and Laboratory Biomarkers in the Risk Stratification of COVID-19 Patients Admitted to the Emergency Department 6
Role of miR-9 in Modulating NF-κB Signaling and Cytokine Expression in COVID-19 Patients 5
Totale 792
Categoria #
all - tutte 11.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 3 2 1 1 1 2 1 34 4
2021/202270 0 18 20 1 0 0 12 6 0 12 1 0
2022/202342 19 0 2 2 1 0 0 0 5 11 2 0
2023/2024137 1 0 0 4 7 3 0 38 8 10 17 49
2024/2025489 34 70 48 11 33 49 34 24 84 12 17 73
2025/20264 4 0 0 0 0 0 0 0 0 0 0 0
Totale 792